Key Insights

Highlights

Success Rate

100% trial completion (above average)

Related Conditions

Often studied with 19 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07892651Not Yet Recruiting

MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT)

NCT00721591Completed

Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy

Showing all 2 trials

Research Network

Active Sponsors

  • University Of British Columbia1
  • Axiom Bioregistry1
  • University Of Chicago1

Related Conditions

  • Recurrent Pregnancy Loss1
  • Celiac Disease1
  • Antiphospholipid Antibodies1
  • Abortion Habitual1
  • Membranous Nephropathy1

Activity Timeline